Skip to main content
. Author manuscript; available in PMC: 2018 Feb 22.
Published in final edited form as: Semin Neurol. 2017 Dec 5;37(5):510–537. doi: 10.1055/s-0037-1608808

Fig. 7.

Fig. 7

DaTSCAN (FP-CIT) in a healthy control (A) and patients with Parkinson’s disease (B), Alzheimer’s disease (C), and dementia with Lewy bodies (D). Used with permission from Walker Z, Costa DC, Walker RW H, et al. Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002;73(2):134–140.